[Serum levels of intact molecular osteocalcin in children with growth hormone (GH) deficiency during GH therapy: an early predictor of GH therapy].
暂无分享,去创建一个
S. Kanzaki | Y. Seino | T. Kubo | T. Tanaka, | A. Okuno | Y. Tsuchiya | H. Niimi | I. Hibi | S. Suwa | K. Tachibana
[1] S. Kanzaki,et al. Secretion of osteocalcin and its propeptide from human osteoblastic cells: Dissociation of the secretory patterns of osteocalcin and its propeptide , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[2] M. Shiraki,et al. Sandwich immunoassay for intact human osteocalcin. , 1992, Clinical chemistry.
[3] Hiroyuki Tanaka,et al. Serum propeptide and intact molecular osteocalcin in normal children and children with growth hormone (GH) deficiency: a potential marker of bone growth and response to GH therapy. , 1992, The Journal of clinical endocrinology and metabolism.
[4] L. Tatò,et al. Effects of two different regimens of recombinant human growth hormone therapy on the bone mineral density of patients with growth hormone deficiency. , 1991, The Journal of pediatrics.
[5] A. Sartorio,et al. Serum Osteocalcin Levels in Patients with GH Deficiency before and during GH Treatment , 1991, Acta paediatrica Scandinavica.
[6] C. Christiansen,et al. Serum bone Gla protein: a potential marker of growth hormone (GH) deficiency and the response to GH therapy. , 1990, The Journal of clinical endocrinology and metabolism.
[7] S. Mohan,et al. Multiple osteocalcin fragments in human urine and serum as detected by a midmolecule osteocalcin radioimmunoassay. , 1990, The Journal of clinical endocrinology and metabolism.
[8] J B Lian,et al. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. , 1989, Physiological reviews.
[9] H. Tanaka,et al. Cooperation of synthetic insulin-like growth factor I/somatomedin C and 1,25-dihydroxyvitamin D3 on regulation of function in clonal osteoblastic cells. , 1989, Bone and mineral.
[10] N. Katsumata,et al. Serum insulin-like growth factor I (somatomedin-C) level in normal subjects from infancy to adulthood, pituitary dwarfs and normal variant short children. , 1988, Endocrinologia japonica.
[11] N. Skakkebaek,et al. Serum bone Gla-protein as a marker of bone growth in children and adolescents: correlation with age, height, serum insulin-like growth factor I, and serum testosterone. , 1988, The Journal of clinical endocrinology and metabolism.
[12] M. Rechler,et al. Hormonal regulation of human growth. , 1987, The New England journal of medicine.
[13] P. Delmas,et al. Serum bone GLA‐protein in growth hormone deficient children , 1986, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[14] R. Weinstein,et al. Multiple immunoreactive forms of osteocalcin in uremic serum. , 1986, The Journal of clinical investigation.
[15] M. Mizruchi,et al. Osteocalcin in human serum: a circadian rhythm. , 1985, The Journal of clinical endocrinology and metabolism.
[16] L. Deftos,et al. New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease. , 1980, The Journal of clinical investigation.
[17] P. Price,et al. Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[18] G. Saggese,et al. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. , 1993, The Journal of pediatrics.